WorldQuant Millennium Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

WorldQuant Millennium Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-149,282	Closed	-$3.02M	–	646
2025 Q3	$3.02M	Sell	149,282 -12,214	-8%	-$215K	0.01%	338
2025 Q2	$2.71M	Sell	161,496 -186,647	-54%	-$3.01M	0.01%	340
2025 Q1	$5.35M	Buy	348,143 +123,169	+55%	+$2.2M	0.03%	291
2024 Q4	$4.96M	Buy	+224,974	New	+$4.09M	0.03%	293
2018 Q4	–	Sell	-358,032	Closed	-$7.71M	–	321
2018 Q3	$7.71M	Buy	358,032 +293,485	+455%	+$6.81M	0.26%	132
2018 Q2	$1.57M	Buy	+64,547	New	+$1.32M	0.06%	210

Other funds holding TEVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

WorldQuant Millennium Advisors's TEVA Position: Q4 2025 in Review

WorldQuant Millennium Advisors sold out of Teva Pharmaceuticals (TEVA) in Q4 2025, closing a stake of 149,282 shares — an estimated $3.02M sold.

WorldQuant Millennium Advisors first reported a position in TEVA in Q2 2018 and held it in 6 quarters. The position peaked at $7.71M in Q3 2018. 629 funds tracked by Wall St. Rank hold TEVA as of Q4 2025.

WorldQuant Millennium Advisors reported no remaining Teva Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
WorldQuant Millennium Advisors sold 149,282 Teva Pharmaceuticals shares in Q4 2025, an estimated $3.02M.
WorldQuant Millennium Advisors first reported a position in Teva Pharmaceuticals in Q2 2018 and held it in 6 quarters.
WorldQuant Millennium Advisors's Teva Pharmaceuticals position peaked at $7.71M in Q3 2018.
629 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2025.

Based on WorldQuant Millennium Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.